ESR1 has been reported to regulate proliferation in liver cancer (Wang et al., 2021), bladder cancer (Ge et al., 2019), progenitor Leydig cells (Oh et al., 2017), and chondrocytes (Liu et al., 2019). This evidence concerns the gene ESR1 and urinary bladder cancer.